Introduction {#sec1}
============

*Gnetum gnemon* L. is a species of the Gnetaceae family commonly called melinjo in Indonesia, known to be rich in resveratrol derivatives. Its fruit and seeds are used as ordinary food in Indonesia and their extracts have been reported to show several pharmacological activities from in vitro to human studies.^[@ref1]−[@ref6]^ A stilbene monomer, *trans*-resveratrol (**8**) and stilbene oligomers such as gnetin C (**4**), gnemonoside A (**5**), gnemonoside C (**6**), gnemonoside D (**7**), gnetin L, and gnetin E (**9**) have been isolated from the fruit and/or seeds ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref1],[@ref2]^ The oligomers possess a 1,2-diaryldihydrobenzofuran skeleton as a basic structural motif. The relative stereochemistry of two chiral centers in the core has been assigned by NOE experiment,^[@ref1],[@ref2],[@ref7]−[@ref9]^ whereas the absolute configuration has been traditionally elucidated by comparison of its electronic circular dichroism (ECD) spectrum with that of known structures.^[@ref10]−[@ref12]^ In our ongoing search for biologically active components from melinjo seed extract (MSE), we isolated a new minor epimer of **4**, termed 7a-*epi*-gnetin C (**1**) along with known compounds as shown in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}. In this paper, we report the elucidation of structure **1** and structural revision of gnetin L (**2**) to the regioisomer **3**. In addition, a series of resveratrol derivatives shown in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} were submitted to the oxygen radical absorbance capacity (ORAC) assay and evaluated as an antioxidant.

![Structures of natural stilbene derivatives from *G. gnemon* L.](ao0c00910_0001){#fig1}

Results and Discussion {#sec2}
======================

The seeds (endosperms) of melinjo (*G. gnemon* L.), collected in Indonesia, were powdered and extracted with 55% aqueous EtOH. MSE with enzymatic hydrolysis of glucosides was successively subjected to ODS column chromatography, silica gel column chromatography, and reversed phase HPLC to give **1**. The existence of **1** in the MSE was confirmed by analytical HPLC analysis before being treated with the enzyme. The molecular formula of **1** was established as C~28~H~22~O~6~ by HR-ESI-MS spectrum (*m*/*z*: 477.1313 \[M + Na\]^+^; calcd for C~28~H~22~O~6~Na, 477.1314). The ^1^H and ^13^C NMR data ensured a set of 2,3-diaryl-dihydrobenzofuran ring and the connectivity of units A and B supported by HMBC correlations from H-8a to C-11b and C-12b, which indicated that **1** possessed the same planar structure as that of **4** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). The coupling constant between H-7a and H-8a for **1** is 8.3 Hz, whereas for **4** is reported to be 4.5 Hz.^[@ref7]^ These values were diagnostic and the same as the values reported for *cis*-dihydrobenzofuran and its *trans* isomer derived from (−)-ε-viniferin,^[@ref13]^ and the *cis*- and *trans*-dihydrobenzofuran moieties included in suffruticosol D from *Paeonia suffruticosa*,^[@ref14]^ indicating that **1** is in a *cis*-form on the dihydrofuran ring. In comparison between ^1^H NMR chemical shifts of **1** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}) and those of **4** ([Table S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00910/suppl_file/ao0c00910_si_001.pdf)), the *cis* orientation of A~1~ and A~2~ rings in **1** causes up-field shifts for aromatic ring signals of H-2a (Δ −0.22 ppm), H-3a (Δ −0.23 ppm), H-10a (Δ −0.44 ppm), and H-12a (Δ −0.22 ppm) by stacking effects. In addition, the NOESY correlations between vicinal H-7a and H-8a and between two aromatic groups H-2a (6a) and H-10a (14a) further supported a cis-orientation.

###### ^1^H and ^13^C NMR Data for **1** in Acetone-*d*~6~

  position      δ~C~     δ~H~ (*J* in Hz)              HMBC                      NOE
  ------------- -------- ----------------------------- ------------------------- ------------------------
  1a            129.05                                                            
  2a (6a)       129.05   7.00 (2H, d, *J* = 8.7 Hz)    1a, 4a, 6a, 7a            3a (5a), 7a, 10a (14a)
  3a (5a)       115.1    6.61 (2H, d, *J* = 8.7 Hz)    1a, 5a                    2a (6a)
  4a            157.4                                                             
  7a            90.3     5.85 (1H, d, *J* = 8.3 Hz)    1a, 2a (6a), 9a           2a (6a), 8a
  8a            51.7     4.56 (1H, d, *J* = 8.3 Hz)    9a, 10a (14a), 11b, 12b   7a, 10a (14a)
  9a            142.2                                                             
  10a (14a)     108.6    5.73 (2H, d, *J* = 2.3 Hz)    8a, 12a                   2a (6a), 8a
  11a (13a)     158.7                                  10a (14a), 12a             
  12a           101.6    5.99 (1H, t, *J* = 2.3 Hz)    10a (14a), 11a (13a)       
  1b            130.0                                                             
  2b (6b)       128.7    7.45 (2H, d, *J* = 8.2 Hz)    4b, 6b, 7b                7b, 8b
  3b (5b)       116.4    6.86 (1H, d, *J* = 8.2 Hz)    1b, 4b, 5b                 
  4b            158.3                                                             
  7b            129.13   7.11 (1H, d, *J* = 16.5 Hz)   2b (6b), 8b, 9b           2b (6b), 10b, 14b
  8b            126.8    6.99 (1H, d, *J* = 16.5 Hz)   7b, 10b, 14b              2b (6b), 10b, 14b
  9b            140.8                                                             
  10b           99.3     6.72 (2H, d, *J* = 0.9 Hz)    8b, 11b, 12b, 14b         7b, 8b
  11b           162.9                                                             
  12b           117.1                                                             
  13b           155.3                                                             
  14b           108.3    6.62 (2H, d, *J* = 0.9 Hz)    8b, 10b, 12b, 13b         7b, 8b
  11a, 13a-OH            7.85 (2H, s)                  10a (14a), 12a             

The absolute configuration of **1** was determined by the optical data comparison of a phenol derivative **10** derived from both **1** and **4**. Namely, treatment of **1** with a Pd/C catalyst under hydrogen atmosphere at room temperature underwent a reductive opening of the tetrahydrofuran ring at C-7a to give **10** {\[α\]~D~^25^ −60.8 (*c* 0.02, MeOH)} ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Its ^1^H and ^13^C NMR data were identical with those of the reduction product prepared^[@ref15]^ from **4**, and its optical rotation was also nearly equal in sign and magnitude^[@ref16]^ to that of **10** {\[α\]~D~^26^ −66.8 (*c* 0.11, MeOH)} derived from **4** {\[α\]~D~^25^ −18.5 (*c* 0.1, MeOH)}, indicating that the configuration of C-8a of **1** was the same as **4**. Therefore, **1** was determined to be the C-7a epimer of **4**.

![Preparation of **10** by Hydrogenation of **1** or **4**](ao0c00910_0005){#sch1}

The absolute configuration of (−)-gnetin C (shown as **4** in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}) was reported to be 7a*S*,8a*S* by a vibrational circular dichroism (VCD) study.^[@ref17]^ We independently ensured this assignment using a fully methylated benzaldehyde derivative, **12** prepared from **4** via **11** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). This compound was designed in order to suppress the effect of hydrogen bonding^[@ref18]^ and the free rotation of a terminal styryl unit. As expected, the experimental ECD spectrum of **12** showed good agreement with the calculated one for (7a*S*,8a*S*)-**12** at ca. 210 nm, a strong positive band at ca. 245 nm, a broad negative band at ca. 280 nm, and a broad positive band at ca. 325 nm ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Meanwhile, the theoretical ECD spectrum calculated for (7a*R*,8a*S*)-**12** exhibited a different feature to that of the experimental one. From these results, the absolute configuration of the parent compound **4** was unambiguously assigned as 7a*S*,8a*S*, which is consistent with the previous result.^[@ref17]^ Thus, the absolute configuration of the new compound **1** was determined as 7a*R*,8a*S*.

![Calculated and experimental ECD spectra of **12**.](ao0c00910_0002){#fig2}

![Chemical Conversion of **4** into a Benzaldehyde Derivative **12**](ao0c00910_0006){#sch2}

In the course of identifying other isolated compounds, we found that NMR spectral data in acetone-*d*~6~ of **3** was almost identical to those of gnetin L (**2**)^[@ref2]^ with a 3-hydroxy-5-methoxyphenyl group. The ^1^H NMR spectra of the isolated **3** in acetone-*d*~6,~ chemical shifts of some aromatic signals were overlapped and second order effects were observed. To clarify the substitution pattern of aromatic rings, we tried to measure ^1^H NMR spectra in several solvent systems. In the ^1^H NMR spectra of **3** in CD~3~CN, the three proton signals in the A~1~ ring were observed at 6.76, 6.80, and 6.92 ppm as doublet of doublets (*J* = 7.8, 1.8 Hz), doublet (*J* = 7.8 Hz), and doublet (*J* = 1.8 Hz), respectively ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). The ortho-coupling protons at δ~H~ 6.76 and 6.80 (*J* = 7.8 Hz) and meta-coupling protons at δ~H~ 6.76 and 6.92 (*J* = 1.8 Hz) proposed an ABX system of 4-hydroxy-3-methoxyphenyl group for the A~1~ ring. In addition, the HMBC correlation peak from the hydroxy proton signal at δ~H~ 6.57 (1H, s) to δ~C~ 115.6 (C-5a) indicated that the hydroxy group was attached to the C-4a position ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). Thus, we concluded that the structure of natural gnetin L should be revised to be the regioisomer **3**. This structural revision of gnetin L (**3**) revealed that gnetin L^[@ref2]^ and the later reported macrostachyol D by Sri-in et al. in 2011 were identical.^[@ref19]^

![Expanded ^1^H NMR spectra in comparison with spin--spin coupling patterns for 4-hydroxy-3-methoxyphenyl ring portion of **3** in acetone-*d*~6~ (a) and CD~3~CN (b).](ao0c00910_0003){#fig3}

![HMBC correlations for **3** in CD~3~CN.](ao0c00910_0004){#fig4}

Finally, we have tested the antioxidant activities of the new as well as known compounds, as it is well known that polyphenols have potentially high antioxidant activities.^[@ref20]^ As listed in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, all tested compounds showed stronger ORAC activity compared with [l]{.smallcaps}-ascorbic acid ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Compounds **1** and **3** were less active than **4**, indicating that a change in the stereochemistry of C-7a in A~1~ ring and the methoxy group at C-3a in A~1~ ring decreased the activity. In addition, compounds **5--7** were less active than **4**, indicating that glucosylation of the hydroxyl group at C-4a in A~1~ ring and at C-4b in B~1~ ring decreased the activity. Although the glucosyl substitution effects of the hydroxyl group in A~1~ and B~1~ ring on DPPH radical scavenging activity reported by Kato et al. in 2009 were very small, the number and position of free phenolic hydroxyl groups in the molecule will contribute to the antioxidant activity as well as other polyphenols. Furthermore, the activity of **9** was 4-fold less active than **4** and **8**. This suggested that a molecule larger than a dimer is less effective as an antioxidant.

###### ORAC Antioxidant Capacity per mol of Stilbene Oligomers and [l]{.smallcaps}-Ascorbic Acid[a](#t2fn1){ref-type="table-fn"}

  compound                                                        type[b](#t2fn2){ref-type="table-fn"}              mmol TE/mol[c](#t2fn3){ref-type="table-fn"}
  --------------------------------------------------------------- ------------------------------------------------- ---------------------------------------------
  7a-*epi*-gnetin C (**1**)                                       resveratrol dimer                                 5081 ± 420
  gnetin L (**3**)                                                a resveratrol unit and an isorhapontigenin unit   5298 ± 414
  gnetin C (**4**)                                                resveratrol dimer                                 8597 ± 619
  gnemonoside A (**5**)                                           resveratrol dimer                                 4679 ± 586
  gnemonoside C (**6**)                                           resveratrol dimer                                 6336 ± 627
  gnemonoside D (**7**)                                           resveratrol dimer                                 5663 ± 997
  *trans*-resveratrol (**8**)                                     resveratrol monomer                               8241 ± 350
  gnetin E (**9**)                                                resveratrol trimer                                2129 ± 237
  [l]{.smallcaps}-ascorbic acid[d](#t2fn4){ref-type="table-fn"}   −                                                 638 ± 59

Data are expressed as the mean ± SD of three experiments.

This classification was based on the structure of **8** as a monomer.

Data are expressed as Trolox equivalent per 1 mol sample.

[l]{.smallcaps}-Ascorbic acid was used as positive control.^[@ref26]^

Methods {#sec3}
=======

General Procedures {#sec3.1}
------------------

All melting points were determined with a Yanaco MP-500 apparatus and are uncorrected. Optical rotations were measured using a JASCO DIP-370 digital polarimeter. IR spectra were recorded by the attenuated total reflection method using ZnSe prism on a JASCO VALOR-III spectrophotometer. ^1^H and ^13^C NMR spectra were recorded at 500 and 125 MHz or 600 and 150 MHz with Agilent Technologies V500 or JEOL ECA600 spectrometers. Chemical shifts were referenced to a residual signal (^1^H) and a solvent signal (^13^C) of CD~3~CN (δ~H~ 1.93, δ~C~ 118.3), acetone-*d*~6~ (δ~H~ 2.04, δ~C~ 29.8), CD~3~OD (δ~H~ 3.30, δ~C~ 49.0), and CDCl~3~ (δ~H~ 7.26, δ~C~ 77.0). ESIMS were recorded on a JEOL JMS-T100LC mass spectrometer. Preparative HPLC was conducted on a Waters 600E system with a Cosmosil 5C~18~-AR-II column (250 mm × 20 mmID, Nacalai Tesque). Medium-pressure liquid chromatography (MPLC) was carried out on a Yamazen MPLC system. Merck precoated silica gel 60 F254 plates, 0.25 mm in thickness, were used for analytical thin-layer chromatography.

Plant Material {#sec3.2}
--------------

The seeds (endosperms) of melinjo were collected in Indonesia (Desa Bangkok, Kecamatan Gurah Kabupaten Kediri, Kediri, Jawa Timur) in July 2009 and have been identified by Dr. Eishin Kato. Voucher specimens (number 090716) have been deposited at Hosoda SHC Co. Ltd., Fukui, Japan.

Extraction and Isolation {#sec3.3}
------------------------

The preparation of MSE and isolation of **4--7** were performed based on the modified method reported by Kato et al.^[@ref2]^ In brief, the powder of dried endosperms of melinjo was extracted with 55% aqueous ethanol, and the MSE (23.0 g) was subjected to ODS column chromatography, silica gel column chromatography, and recrystallization and/or preparative HPLC to give **4** (0.19 g), **5** (1.15 g), **6** (62 mg), and **7** (0.23 g).

The MSE (150 g) was treated with 3 g of β-glucosidase in 0.02 M citric acid (12 L) at 40 °C for 24 h. The hydrolyzed residue (120 g) was subjected to Daiso Gel column chromatography (Daiso gel IR-60, 600 mm × 80 mmID) with 9 L (each 1 L/fraction) of 6, 12, and 25% MeOH in CHCl~3~ as the eluent. The fraction eluted with 25% MeOH in CHCl~3~ was further purified by MPLC using ODS column chromatography (Hi-Flash Column ODS-SM, 100 mm × 26 mmID, Yamazen) using aqueous MeOH (20--80%, 54 min linear, 100%, 10 min hold) with 0.1% TFA as the eluent at a flow rate of 15 mL/min (15 mL × 64). Fraction 31--33 was then purified by preparative HPLC using aqueous MeOH (48--50%, 60 min linear, 50--55%, 60 min linear, 55%, 30 min hold) with 0.1% TFA at a flow rate of 7.5 mL/min to give **9**([@ref21]) (*t*~R~ = 124 min, 1.82 mg ≥ 99% HPLC). Furthermore, the hydrolyzed residue (70 g) was subjected to ODS column chromatography (Cosmosil 75C~18~-PREP, 400 mm × 80 mmID, Nacalai Tesque) with 6 L (each 1 L/fraction) of 20, 40, 60, and 100% aqueous MeOH. The third and fourth fractions eluted with 40% aqueous MeOH were subjected to MPLC using ultra pack silica gel column (300 mm × 37 mmID, Yamazen) with MeOH (10%, 15 min hold, 10--20%, 45 min linear, 20--50%, 45 min linear, 50%, 60 min hold) in CHCl~3~ as the eluent at a flow rate of 20 mL/min (20 mL × 120). Fraction 27--30 was further purified by preparative HPLC using aqueous MeOH (43--46%, 30 min linear, 46%, 150 min hold) with 0.1% TFA at a flow rate of 7.5 mL/min to give fractions that eluted at 117 and 133 min to give **1** (1.82 mg ≥ 99% HPLC) and **3** (3.59 mg ≥ 99% HPLC), respectively.

7a-*epi*-Gnetin C (**1**): \[α\]~D~^26^ + 201 (*c* 0.11, MeOH); IR (ZnSe) ν~max~: 3235, 2932, 2840, 1670, 1595, 1509, 1448, 1429, 1251, 1194, 1142, 998, 821, and 799 cm^--1^; ^1^H and ^13^C NMR (600 and 150 MHz, acetone-*d*~6~), see [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}; HRESIMS *m*/*z*: 477.1313 \[M + Na\]^+^ (calcd for C~28~H~22~O~6~Na, 477.1314).

Gnetin L (**3**): ^1^H and ^13^C NMR (600 and 150 MHz, CD~3~CN), see [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00910/suppl_file/ao0c00910_si_001.pdf).

Gnetin E (**9**): ^1^H and ^13^C NMR (600 and 150 MHz, acetone-*d*~6~), see [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00910/suppl_file/ao0c00910_si_001.pdf).

Analysis of Resveratrol Derivatives {#sec3.4}
-----------------------------------

Analysis of resveratrol derivatives in MSE was performed by the Prominence HPLC system (Shimadzu) with a Cosmosil 5C~18~-AR-II column (250 mm × 4.6 mmID, Nacalai Tesque), following the analysis conditions previously reported.^[@ref22]^ The contents of dimer derivatives in MSE were as follows: 1.5 mg/g **1**, 2.2 mg/g **3**, 28 mg/g **4**, 101 mg/g **5**, 16 mg/g **6**, 48 mg/g **7**, and 0.3 mg/g **8**.

(*S*)-2-(1-(3,5-Dihydroxyphenyl)-2-(4-hydroxyphenyl)ethyl)-5-(4-hydroxyphenethyl)benzene-1,3-diol (**10**) {#sec3.5}
----------------------------------------------------------------------------------------------------------

From **4**. To a stirred solution of gnetin C (10.2 mg, 22.4 μmol) in ethyl acetate (2.0 mL) was added 10% Pd/C (16.1 mg). The mixture was stirred vigorously under a hydrogen atmosphere at room temperature (rt) for 22 h, filtered through a pad of Celite, and then concentrated. The residue was purified by preparative TLC (dichloromethane/methanol = 10:1, 3 developments) to give **10** (7.0 mg, 68%) as an amorphous solid: \[α\]~D~^26^ −66.8 (*c* 0.11, MeOH); IR (ZnSe) ν~max~: 3200, 2920, 2843, 1590, 1510, 1423, 1240, 1219, 1142, 1000, and 818 cm^--1^; ^1^H NMR (500 MHz, CD~3~OD): δ 6.95 (2H, d, *J* = 8.6 Hz), 6.91 (2H, d, *J* = 8.6 Hz), 6.65 (2H, d, *J* = 8.6 Hz), 6.55 (2H, d, *J* = 8.6 Hz), 6.46 (2H, brd, *J* = 2.2 Hz), 6.04 (2H, s), 6.02 (1H, t, *J* = 2.2 Hz), 4.65 (1H, dd, *J* = 9.5, 6.6 Hz), 3.53 (1H, dd, *J* = 13.4, 9.5 Hz), 3.26 (1H, dd, *J* = 13.4, 6.6 Hz), 2.74--2.66 (2H, m), and 2.59--2.55 (2H, m); ^13^C NMR (150 MHz, CD~3~OD): δ 158.5, 157.6, 156.3, 155.7, 149.6, 142.2, 134.6, 134.3, 130.9, 130.4, 116.2, 116.0, 115.4, 108.34, 108.26, 100.6, 43.4, 39.3, 38.5, and 38.1; HRESIMS *m*/*z*: 481.1620 \[M + Na\]^+^ (calcd for C~28~H~26~O~6~Na, 481.1627).

From **1**. To a stirred solution of **1** (1.10 mg, 2.42 μmol) in methanol (0.5 mL) was added 10% Pd/C (2.5 mg). The mixture was stirred vigorously under a hydrogen atmosphere at rt for 9 h, filtered through a pad of Celite, and then concentrated. The residue was purified by preparative TLC (dichloromethane/methanol = 10:1, 5 developments) to give **10** (0.61 mg, 55%) as an amorphous solid whose spectral data were identical with those of an authentic sample derived from gnetin C: \[α\]~D~^25^ −60.8 (*c* 0.02, MeOH); HRESIMS *m*/*z*: 481.1627 (calcd for C~28~H~26~O~6~Na \[M + Na\]^+^, 481.1627).

Permethylation of Gnetin C (**11**) {#sec3.6}
-----------------------------------

To a stirred suspension of **4** (10.4 mg, 22.9 μmol) and potassium carbonate (61 mg, 441 μmol) in acetone (0.5 mL) was added methyl iodide (27.4 μL, 441 μmol), and the mixture was stirred under reflux for 2 h. More methyl iodide (27.4 μL, 441 μmol) and acetone (0.5 mL) were added and the reaction was further continued for 3 h. After cooling to rt, the reaction mixture was concentrated, diluted with dichloromethane/methanol (20:1), filtered through a pad of Celite, and then concentrated. The residue was purified by preparative TLC (*n*-hexane/ethyl acetate = 2:1, 3 developments) to give **11** (11.2 mg, 97%) as an amorphous solid: \[α\]~D~^27^ + 1.2 (*c* 0.41, CHCl~3~); IR (ZnSe) ν~max~: 2920, 2820, 1583, 1505, 1453, 1420, 1241, 1165, 1150, 1023, 821, and 741 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~), see [Table S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00910/suppl_file/ao0c00910_si_001.pdf); ^13^C NMR (125 MHz, CDCl~3~): δ 161.6, 160.8, 159.4, 159.3, 156.9, 145.2, 140.3, 133.9, 130.0, 128.4, 127.8, 126.9, 126.8, 115.2, 114.1, 113.9, 105.5, 102.5, 100.4, 98.6, 92.8, 55.7, 55.4, 55.3, and 55.2; HRESIMS *m*/*z*: 547.2095 \[M + Na\]^+^ (calcd for C~33~H~32~O~6~Na, 547.2097).

(2*S*,3*S*)-3-(3,5-Dimethoxyphenyl)-4-methoxy-2-(4-methoxyphenyl)-2,3-dihydrobenzofuran-6-carbaldehyde (**12**) {#sec3.7}
---------------------------------------------------------------------------------------------------------------

To a stirred solution of **11** (11.0 mg, 21.0 μmol) in tetrahydrofuran (0.5 mL) and water (0.2 mL) was added dropwise a solution of OsO~4~ (ca. 5 μmol) in 2-methyl-2-propanol (50 μL) at rt. After stirring for few minutes, NaIO~4~ (43 mg, 0.20 mmol) was added by portions. After being stirred for an additional 3 h, the mixture was filtered through a pad of Celite. The filtrate was diluted with ethyl acetate, washed successively with aqueous Na~2~S, water, and brine, dried, and concentrated. The residue was purified by preparative TLC (*n*-hexane/ethyl acetate = 4:1, 3 developments) to give **12** (7.0 mg, 80%) as an amorphous solid: \[α\]~D~^26^ + 106.4 (*c* 0.23, CHCl~3~); IR (ZnSe) ν~max~: 2920, 2808, 1685, 1585, 1508, 1450, 1420, 1195, 1150, 1080, 1060, 820, and 745 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~), see [Table S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00910/suppl_file/ao0c00910_si_001.pdf); ^13^C NMR (125 MHz, CDCl~3~): δ 191.6, 161.5, 160.9, 159.7, 157.3, 144.2, 139.1, 133.2, 126.8, 123.0, 114.1, 105.6, 105.3, 104.3, 98.7, 93.2, 55.7, 55.6, and 55.3; HRESIMS *m*/*z*: 443.1473 \[M + Na\]^+^ (calcd for C~25~H~24~O~6~Na, 443.1471).

ECD Calculation {#sec3.8}
---------------

ECD calculations of (7a*S*,8a*S*)-**12** were initiated with a preliminary MMFF conformational search on a Spartan'10 program.^[@ref23]^ The lower energy conformers within 2.4 kcal/mol from the most stable were optimized at the DFT/B3LYP/6-31G(d) level using a Gaussian 09 program.^[@ref24]^ The resultant stable conformers within 2.0 kcal/mol, from the most stable ones, were further submitted to a DFT/B3LYP/6-311G(d,p) optimization considering the solvent effects. The ECD spectra of the obtained 10 conformers within 1.0 kcal/mol, from the most stable ones, were calculated at the TDDFT/B3LYP/6-311G(d,p) level. The first 55 singlet → singlet electronic transitions were considered. The calculated ECD spectra in Δε unit were obtained by using Gaussian band shapes with 0.15 eV half-width at 1/*e* of peak height.

ORAC Assay {#sec3.9}
----------

The ORAC analysis has been performed following the method^[@ref25]^ reported by Shimizu et al. with minor modifications. In brief, a sample was dissolved directly in an ethanol/water mixture (50:50, v/v) and diluted with phosphate buffer (75 mM, pH 7.4). The sample solution (20 μL) was transferred to a 96-well microplate, and then fluorescein (200 μL, 94.4 nM) and AAPH (75 μL, 63.4 mM) were added and mixed. Phosphate buffer (75 mM, pH 7.4) was used as a blank solution, and Trolox as the standard solution. The assay was carried out on a FLUOstar OPTIMA plate reader utilizing fluorescence filters with 485 nm excitation and 520 nm emission. The antioxidant capacity of the sample was calculated as mmol Trolox equivalent per mol (mmol TE/mol).

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c00910](https://pubs.acs.org/doi/10.1021/acsomega.0c00910?goto=supporting-info).^1^H and ^13^C NMR spectra for **1**, **3**, **10**, **11**, and **12**; FT-IR and MS spectra for **1**; and NMR data for **3**, **4**, **9**, **11**, and **12** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c00910/suppl_file/ao0c00910_si_001.pdf))
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